Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-13-027714
Filing Date
2013-04-08
Accepted
2013-04-08 17:07:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a13-9628_1s3.htm S-3 559945
2 EX-5.1 a13-9628_1ex5d1.htm EX-5.1 46869
3 EX-23.1 a13-9628_1ex23d1.htm EX-23.1 2881
4 EX-23.2 a13-9628_1ex23d2.htm EX-23.2 4428
5 GRAPHIC g96281kei001.jpg GRAPHIC 2636
  Complete submission text file 0001104659-13-027714.txt   618999
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-187801 | Film No.: 13748953
SIC: 2834 Pharmaceutical Preparations